Other substances

MB_266

An experimental antimalarial.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

MB_266 is an experimental antimalarial drug (Ahmad et al., 2020).

 

C1(OC(CC1)C1CCC(CC1CL)[NH2]C(=[NH2])[NH3])C1CCC(CC1CL)[NH2]C(=[NH2])[NH3]

Supporting references

Link Tested on Impact factor Notes Publication date
Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies
3CLpro Small molecule In silico 		in silico 3.26

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Oct/24/2020
Export (.csv)